这个深圳最年轻的行政区，何以成为生物医药创新高地？

时代财经10-24

本文来源：时代财经作者：文若楠图片来源：深圳市光明区随着一系列产业政策和金融资金支持的陆续出台，深圳市光明区生物医药产业规模正不断壮大。作为综合性国家科学中心核心承载区，以及深圳市“生物医药技术创新区”，近年来，光明区生物医药产业集群效应日益凸显。依托丰富的科技创新资源，光明区快速集聚合成生物研究、脑解析与脑模拟等科学设施，深圳湾实验室、深圳医学科学院等高端平台载体，高品质打造卫光生命科学园、...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477577374?lang=zh_CN&edition=full","thumbnail":"https://inews.gtimg.com/om_ls/OqVX7ClWljI-yHIqpXNYFdVGqVz_DPeUJlmX7znggiquAAA_294195/0","is_english":false,"pubTime":"2024-10-24 15:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2477577374","market":"us","top_or_hot":-1,"title":"这个深圳最年轻的行政区，何以成为生物医药创新高地？","media":"时代财经","content":"<div>\n<p>本文来源：时代财经 作者：文若楠图片来源：深圳市光明区随着一系列产业政策和金融资金支持的陆续出台，深圳市光明区生物医药产业规模正不断壮大。作为综合性国家科学中心核心承载区，以及深圳市“生物医药技术创新区”，近年来，光明区生物医药产业集群效应日益凸显。依托丰富的科技创新资源，光明区快速集聚合成生物研究、脑解析与脑模拟等科学设施，深圳湾实验室、深圳医学科学院等高端平台载体，高品质打造卫光生命科学园、...</p>\n\n<a href=\"https://new.qq.com/rain/a/20241024A05OJ200\">网页链接</a>\n\n</div>\n","source":"tencent_tech","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>这个深圳最年轻的行政区，何以成为生物医药创新高地？</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n这个深圳最年轻的行政区，何以成为生物医药创新高地？\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-24 15:37 北京时间&nbsp;&nbsp;&nbsp;<a href=https://new.qq.com/rain/a/20241024A05OJ200><strong>时代财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>本文来源：时代财经 作者：文若楠图片来源：深圳市光明区随着一系列产业政策和金融资金支持的陆续出台，深圳市光明区生物医药产业规模正不断壮大。作为综合性国家科学中心核心承载区，以及深圳市“生物医药技术创新区”，近年来，光明区生物医药产业集群效应日益凸显。依托丰富的科技创新资源，光明区快速集聚合成生物研究、脑解析与脑模拟等科学设施，深圳湾实验室、深圳医学科学院等高端平台载体，高品质打造卫光生命科学园、...</p>\n\n<a href=\"https://new.qq.com/rain/a/20241024A05OJ200\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1066051811.HKD","symbol_name":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","start_time":0,"source_url":"https://new.qq.com/rain/a/20241024A05OJ200","article_id":"2477577374","we_media_id":null,"thumbnails":["https://inews.gtimg.com/om_ls/OqVX7ClWljI-yHIqpXNYFdVGqVz_DPeUJlmX7znggiquAAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241024A05OJ200","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477577374","pubTimestamp":1729755429,"sourceInfo":{"source_id":"tencent_tech","name":"腾讯科技"},"weMediaInfo":null,"summary":"本文来源：时代财经 作者：文若楠                                                图片来源：深圳市光明区                    随着一系列产业政策和金融资金支持的陆续出台，深圳市光明区生物医药产业规模正不断壮大。作为综合性国家科学中心核心承载区，以及深圳市“生物医药技术创新区”，近年来，光明区生物医药产业...","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","LU1934455277.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"AD\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0234572021.USD":"高盛美国核心股票组合Acc","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","LU1037948541.HKD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (HKD) ACC","BK4516":"特朗普概念","LU1941712264.USD":"ALLIANZ PET AND ANIMAL WELLBEING \"A\" (USD) INC","LU1934455194.USD":"AB SICAV I LOW VOLATILITY TOTAL RETURN EQUITY PORT \"A\" (USD) ACC","LU0058720904.USD":"联博国际健康护理基金A","LU0965509010.AUD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (AUDHDG) INC","LU1061106388.HKD":"BGF WORLD HEALTHSCIENCE \"A2\" (HKDHDG) ACC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","BK4534":"瑞士信贷持仓","BK4585":"ETF&股票定投概念","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","LU0965508806.USD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (USD) INC","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0106261372.USD":"SCHRODER ISF US LARGE CAP \"A\" ACC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","LU0965509283.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"AD\" (SGDHDG) INC","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU0203347892.USD":"SCHRODER ISF QEP GLOBAL ACTIVE VALLUE \"A\" (USD)  INC AV","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","BK4559":"巴菲特持仓","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK4588":"碎股","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","BK4550":"红杉资本持仓","LU0965509101.SGD":"AB LOW VOLATILITY EQUITY PORTFOLIO \"A\" (SGDHDG) ACC","LU1585245621.USD":"EASTSPRING INV GLOBAL LOW VOLATILITY EQUITY FUND \"A\" (USD) ACC B","MRK":"默沙东","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","LU0238689110.USD":"贝莱德环球动力股票基金","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC"},"translate_title":"Why has this youngest administrative district in Shenzhen become a highland of biomedical innovation?","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRK":0.9},"content_text":"本文来源：时代财经 作者：文若楠图片来源：深圳市光明区随着一系列产业政策和金融资金支持的陆续出台，深圳市光明区生物医药产业规模正不断壮大。作为综合性国家科学中心核心承载区，以及深圳市“生物医药技术创新区”，近年来，光明区生物医药产业集群效应日益凸显。依托丰富的科技创新资源，光明区快速集聚合成生物研究、脑解析与脑模拟等科学设施，深圳湾实验室、深圳医学科学院等高端平台载体，高品质打造卫光生命科学园、光明银智生命健康科技园等专业产业空间，在细胞与基因治疗、新型疫苗、抗体药等领域极具技术研发攻关能力和产业发展潜力。随着创新要素持续完善，光明区已逐步构建起涵盖原料供应、制剂生产，仿制药、创新药开发等环节的生物医药产业体系。经统计，2024年上半年，光明区生物医药产业集群实现产值54.78亿元，增加值19.80亿元。“在生物科技领域，新质生产力表现尤为突出。随着细胞治疗、合成生物学等前沿技术不断发展，生物科技产业正经历一场深刻的变革。这些新技术不仅为疾病的诊断和治疗提供了新的手段，也为生物科技及相关产业创新发展注入新的动力。”在10月21日-22日举办的“第二届国际生物科技创新与投资大会”期间，中国外商投资企业协会副会长原高强表示。2018年，光明区揭牌成立，是深圳市最年轻的行政区。近年来，光明区大力发展生物医药产业，创新载体布局持续丰富，龙头企业集聚效应开始显现，产业规模不断扩大，正着力建设成为生物医药产业集聚发展的新高地。中国食药促进会副会长、同写意论坛发起人程增江对时代财经指出，“深圳市在营造创新生态上非常积极，我多次来到光明区，充分感受到无论是设施还是其他创新生态上的建设，都变化非常大，吸引了四面八方的创新资源在此落户，在产业基地建设上也有明显进展，让大家感受到这里的朝气蓬勃。”目前，光明区已成为粤港澳大湾区重大科技创新载体布局集中、创新动能汇聚迅速、综合创新投入力度大的重点区域，集聚了院士50余名、各领域高层次人才超2700人、科研院所人才超7000人，人才总量超18万人。随着跨国药企与本土企业的合作愈发紧密，背靠超大市场优势的粤港澳大湾区正成为跨国药企投资合作的优选地。在此次大会期间，默克生命科学副总裁、生命科学中国区董事总经理吴波博士告诉时代财经，默克方面已经把大湾区作为中国的主要战略布局区域之一，这次在深圳第二届国际生物制药创新与投资大会期间举办的“默克日主题”活动，就是为了促进大湾区生物制药和体外诊断行业的生态圈发展，打造一个打通上下游的合作平台。这将有助于加速新药和新体外诊断产品研发，推广先进的生物制药和体外诊断技术应用，赋能创新企业，并最终提高优质药物和新兴体外诊断产品的可及性。今年已经356岁的默克将自己定义为一家领先的科技公司，从治疗最具挑战性疾病的疗法，到实现设备的智能化，业务覆盖广泛，影响深远。在中国，默克医药健康建立了包括研发、制造、供应和销售的全价值链，覆盖心血管、代谢及内分泌，辅助生殖，肿瘤及神经免疫四大疾病领域。近年来，默克生命科学业务在华领导层多次调研考察大湾区，与生物制药行业，以及相邻和新领域产业积极交流。“经过长时间的发展，很多中国生物医药和体外诊断企业已经逐步与国际水平接轨，有些赛道已经走在世界前列。另一方面，在国内集采和风投变寒的压力下，诸多企业会考虑License-out（对外授权）或者直接出海，以融入国际市场，这个过程中了解合规和熟悉国外的法规和监管要求就变得至关重要，我们很高兴看到在此次大会上很多讨论关于如何帮助中国企业加入适应国外法规，加速上市，进入国际市场。”吴波博士对时代财经说。查看原图 1.4M","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477577374"}